Évaluation de la satisfaction des Français à l’égard de la vaccination Covid-19 en officine - 13/09/22
Evaluation of the satisfaction of the French with the Covid-19 vaccination in pharmacies
![](/templates/common/images/mail.png)
Riassunto |
La vaccination contre la Covid-19 fait partie des mesures les plus efficaces pour réduire les formes graves et les décès dus au Sars-CoV-2. Pour améliorer l’accessibilité aux vaccins, les pharmaciens français ont été autorisés à les prescrire et les administrer en mars 2021. L’étude PharmaCoVax, qui vise à évaluer la satisfaction des usagers ayant bénéficié de ce service, a été menée dans les officines du 16 mars au 30 juin 2021.
Il testo completo di questo articolo è disponibile in PDF.Evaluation of the satisfaction of the French with the Covid-19 vaccination in pharmacies |
Vaccination against Covid-19 is among the most effective measures to reduce severe forms and deaths from Sars-CoV-2. To improve accessibility to the vaccines, French pharmacists were authorized to prescribe and administer them in March 2021. The PharmaCoVax study, which aims to assess the satisfaction of users who have benefited from this service, was conducted in pharmacies from March 16 to June 30, 2021.
Il testo completo di questo articolo è disponibile in PDF.Mots clés : Covid-19, nouvelle mission, pharmacien, prévention, soin primaire, vaccination
Keywords : Covid-19, new mission, pharmacist, prevention, primary care, vaccination
Mappa
Vol 61 - N° 618
P. 41-46 - Settembre 2022 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.